
Imeik Technology Development Co Ltd
SZSE:300896

US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
134.05
282.72
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

Intrinsic Value
The intrinsic value of one
Imeik Technology Development Co Ltd
stock under the Base Case scenario is
202.06
CNY.
Compared to the current market price of 174.11 CNY,
Imeik Technology Development Co Ltd
is
Undervalued by 14%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Imeik Technology Development Co Ltd
Loading...
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
US |
E
|
Epizyme Inc
F:EPE
|
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
US |
S
|
Seagen Inc
F:SGT
|
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Fundamental Analysis

Select up to 3 indicators:
Select up to 3 indicators:


Revenue & Expenses Breakdown
Imeik Technology Development Co Ltd
Balance Sheet Decomposition
Imeik Technology Development Co Ltd
Current Assets | 5B |
Cash & Short-Term Investments | 4.7B |
Receivables | 209.1m |
Other Current Assets | 99.4m |
Non-Current Assets | 3.3B |
Long-Term Investments | 2.3B |
PP&E | 539.6m |
Intangibles | 388.4m |
Other Non-Current Assets | 87.6m |
Current Liabilities | 343.9m |
Accounts Payable | 83m |
Accrued Liabilities | 122.6m |
Other Current Liabilities | 138.3m |
Non-Current Liabilities | 199.5m |
Long-Term Debt | 26m |
Other Non-Current Liabilities | 173.5m |
Free Cash Flow Analysis
Imeik Technology Development Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Imeik Technology Development Co Ltd
Revenue
|
2.9B
CNY
|
Cost of Revenue
|
-180.3m
CNY
|
Gross Profit
|
2.7B
CNY
|
Operating Expenses
|
-667.6m
CNY
|
Operating Income
|
2B
CNY
|
Other Expenses
|
-159.3m
CNY
|
Net Income
|
1.9B
CNY
|
Profitability Score
Profitability Due Diligence
Imeik Technology Development Co Ltd's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

Score
Imeik Technology Development Co Ltd's profitability score is 75/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Imeik Technology Development Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Score
Imeik Technology Development Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Imeik Technology Development Co Ltd
According to Wall Street analysts, the average 1-year price target for
Imeik Technology Development Co Ltd
is 224.74 CNY
with a low forecast of 177.76 CNY and a high forecast of 314.44 CNY.
Dividends
Current shareholder yield for Imeik Technology Development Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Imeik Technology Development Co Ltd
stock under the Base Case scenario is
202.06
CNY.
Compared to the current market price of 174.11 CNY,
Imeik Technology Development Co Ltd
is
Undervalued by 14%.